COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

COVID-19 enzyme immuno assay/enzyme linked immunosorbent assay (EIA/ELISA) is the most widely used assays having high sensitivity and specificity. They are used to detect the recombinant protein and peptide antigens in the samples. The COVID-19 EIA/ELISA pipeline product report provides comprehensive information about the pipeline products with comparative analysis at various stages of development and information about the clinical trials which are in progress. The report also provides key information and clinical trial data regarding ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major COVID-19 enzyme immuno assay/enzyme linked immunosorbent assay pipeline products.

Which are the key territories covered in the COVID-19 enzyme immuno assay/enzyme linked immunosorbent assay pipeline product market?

The US accounts for the highest number of COVID-19 EIA/ELISA pipeline products in the market followed by Canada and Europe. The other top territories include India, China, Australia, Brazil, Japan, Taiwan, the UK, Argentina, Mexico, New Zealand, Singapore, South Africa, South Korea, Chile, Colombia, Costa Rica, Ecuador, and El Salvador.

COVID-19 EIA/ELISA pipeline product market, by territory

COVID-19 EIA/ELISA pipeline product market, by territory

For more regional insights, download a free report sample

What are the different stages of development in the COVID-19 enzyme immuno assay/enzyme linked immunosorbent assay pipeline product market?

The maximum number of pipeline products in the market is in the approval process. More than 50 are in the clinical process and over 40 are in the early development process. EUA is the most popular regulatory path taken for the approval of enzyme immuno EIA/ELISA pipeline products. As of November 2021, it has been estimated that by 2022, one of the pipeline products will be approved.

COVID-19 EIA/ELISA pipeline product market, by stage of developmentCOVID-19 EIA/ELISA pipeline product market, by stage of development

For more stage of development insights, download a free report sample

Which are the major companies in the COVID-19 enzyme immuno assay/enzyme linked immunosorbent assay pipeline product market?

The key companies in the COVID-19 EIA/ELISA pipeline product market are 20/20 GeneSystems Inc, Abbott Diagnostics, Abbott Laboratories, Absology Co Ltd, Abwiz Bio Inc, Achira Labs Pvt Ltd, ADiTx Therapeutics Inc, ADMA Biologics Inc, AegirBio AB, Aegis Sciences Corp, Affigenix Biosolutions Pvt Ltd, Agilent Technologies Inc, ALPCO Diagnostics, Anhui Deep Blue Medical Technology Co Ltd, and Ansh Labs LLC.

20/20 GeneSystems Inc: It is a medical diagnostic company that discovers, develops, and commercializes proteomics products and diagnostic tests for therapy selection, early disease detection, and biodefense applications. It provides tests in the areas of early detection of lung cancer, personalized medicine, and biological detection. 20/20 Gene’s blood test technology is used in the early detection of lung cancer and provides a method for analysis of cell signaling in tissue and technologies to detect biological toxins. The company offers its products and services to drug companies, biodefense specialists, and life scientists for protein analysis.

Abbott Diagnostics: It is a subsidiary of Abbott Laboratories. The company manufactures in vitro diagnostic systems and tests. They offer various core laboratory products, molecular point of care products, transfusion medicine, professional services, and a diagnostics portfolio. Abbott products portfolio includes laboratory systems for automation molecular diagnostic systems and point of care systems for blood analysis. The company products find application in therapeutic drug monitoring, measurement of antibodies and antigens, and screening and diagnosis of cancer. Abbott serves blood banks, hospitals, commercial laboratories, government agencies, patient care testing sites, and plasma protein therapeutic companies.

Abbott Laboratories: They discover, develop, manufacture, and sell a diversified range of healthcare products including branded generic pharmaceuticals, diagnostic systems and tests, and pediatric and adult nutritional products. The company also offers various medical devices including heart failure, electrophysiology, rhythm management, vascular and structural heart devices, and neuromodulation devices. The company also offers minerals and nutrition products and various dietary supplements.

Absology Co Ltd: The company manufactures in vitro diagnostic systems and tests. Their product can be used to detect antibodies.

Abwiz Bio Inc: They are involved with manufacturing in vitro diagnostic systems. Their product can be applied for the diagnosis of Coronavirus disease.

COVID-19 EIA/ELISA pipeline product market, by companyCOVID-19 EIA/ELISA pipeline product market, by company

To know more about key companies, download a free report sample

Market report scope

Key territory The US, Canada, Europe, India, China, Australia, Brazil, Japan, Taiwan, the UK, Argentina, Mexico, New Zealand, Singapore, South Africa, South Korea, Chile, Colombia, Costa Rica, Ecuador, and El Salvador
Key stages of development Early Development, Pre-Clinical, Clinical, In-approval, Inactive, and Discontinued
Key regulatory path EUA, CE-IVD, 510(k), MDL, TGA, and ANVISA
Key companies 20/20 GeneSystems Inc, Abbott Diagnostics, Abbott Laboratories, Absology Co Ltd, Abwiz Bio Inc, Achira Labs Pvt Ltd, ADiTx Therapeutics Inc, ADMA Biologics Inc, AegirBio AB, Aegis Sciences Corp, Affigenix Biosolutions Pvt Ltd, Agilent Technologies Inc, ALPCO Diagnostics, Anhui Deep Blue Medical Technology Co Ltd, and Ansh Labs LLC

This report provides an in-depth analysis of the following:

  • Extensive coverage of the COVID-19 enzyme immuno assay/enzyme linked immunosorbent assay (EIA/ELISA) under development.
  • Details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities.
  • The major players involved in the development of COVID-19 enzyme immuno assay/enzyme linked immunosorbent assay (EIA/ELISA) and list all their pipeline projects.
  • The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of COVID 19 enzyme immuno assay/enzyme linked immunosorbent assay (EIA/ELISA) under development.
  • Develop market entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

20/20 GeneSystems Inc
Abbott Diagnostics
Abbott Laboratories
Absology Co Ltd
Abwiz Bio Inc
Achira Labs Pvt Ltd
ADiTx Therapeutics Inc
ADMA Biologics Inc
AegirBio AB
Aegis Sciences Corp
Affigenix Biosolutions Pvt Ltd
Agilent Technologies Inc
ALPCO Diagnostics
Anhui Deep Blue Medical Technology Co Ltd
Ansh Labs LLC
Arrayit Corp
ARUP Laboratories
Avacta Group Plc
Axim Biotechnologies Inc
Axium BioResearch Inc
Babson Diagnostics Inc
Base10 Genetics Inc
Beckman Coulter Inc
Beijing Shengkun Kangru Medical Equipment Co Ltd
Ben-Gurion University of the Negev
Biohit Healthcare Ltd
BioIQ Inc
Biolinker Synthetic Biology Ltd
Biomerica Inc
Bio-Techne Corp
BioVaxys Technology Corp
Bloom Diagnostics AG
Boston University
BreviTest Technologies LLC
Calviri Inc
Capricor Therapeutics Inc
CareHealth America Corp
Cellex Inc
Cellmid Ltd
Celltrion Inc
Core Technology Co Ltd
DiaCarta Inc
Diagnostics Biochem Canada Inc
DIALAB GmbH
DiaSorin SpA
Diazyme Laboratories Inc
DLS Research and Ventures
DRG International Inc
EDP Biotech Corporation
Empower Clinics Inc
Enable Biosciences Inc
Enzo Biochem Inc
Epigentek Group Inc
Epitope Diagnostics, Inc.
Eurobio Scientific SA
Eurofins Scientific SE
Euroimmun AG
Excelsior Bio-Systems Inc
Ezra AI Inc
Fujirebio Diagnostics Inc
General Biologicals Corp
Halberd Corp
Hecin Scientific Inc
Hunan Lituo Biotechnology Co Ltd
Icosagen AS
ICT International
IDvet
Immunodiagnostics Ltd
ImmunoPrecise Antibodies Ltd
Indian Institute of Technology Guwahati
Interpace Biosciences Inc
Kantaro Biosciences LLC
Kephera Diagnostics LLC
KRISHGEN BioSystems
Lansion Biotechnology Co Ltd
Leadgene Biomedical Inc
Leinco Technologies Inc
Liquid Diagnostics LLC
Lumos Diagnostics Inc
Maxim Biomedical Inc
Meridian Bioscience Inc
Module Innovations Pvt Ltd
Mologic Ltd
Monarch Global Health LLC
Monopar Therapeutics Inc
Nanjing Liming Bio-Products Co Ltd
NanoRepro AG
Nirmidas Biotech Inc
Northwestern University
Novacyt SA
NovaTec Immundiagnostica GmbH
Novo Nordisk AS
OraSure Technologies Inc
Ortho Clinical Diagnostics Holdings Plc
Oy Medix Biochemica Ab
P3 Diagnostics LLC
Pepex Biomedical, Inc.
PerkinElmer Inc
Pinnacle BioLabs
Prantae Solutions Pvt Ltd
Premier Medical Corporation
ProAxsis Ltd
ProGnosis Biotech SA
Promega Corp
ProMIS Neurosciences Inc
Qiagen NV
Qlife Holding AB
Quanterix Corp
Quotient Ltd
Randox Laboratories Ltd
Roche Diagnostics International Ltd
Safetest Comercio de Diagnosticos Ltd
Salofa Oy
ScheBo Biotech AG
Sciteck Diagnostics Inc
Shenzhen Kingfocus Biomedical Engineering Co Ltd
Shenzhen Tisenc Medical Devices Co Ltd
Shijiazhuang Hipro Biotechnology Co Ltd
Siemens Healthcare Diagnostics Inc
Siemens Healthineers AG
SQI Diagnostics Inc
St Petersburg Research Institute of Vaccines and Serums
Stream Bio Ltd
Syngene
Sysmex Corp
Taizhou ZECEN Biotech Co Ltd
The Binding Site Inc
ThermoGenesis Holdings Inc
Trinity College Dublin
University of Melbourne
VidaCheck LLC
VirIntel LLC
Vivera Pharmaceuticals Inc
Vyriad Inc
West Virginia University School of Medicine
Zalgen Labs LLC
Zandcell AB
ZRT Laboratory LLC

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 9

|1.2 List of Figures 19

2 Introduction 20

2.1 COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Overview 20

3 Products under Development 21

3.1 COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) – Pipeline Products by Stage of Development 21

3.2 COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) – Pipeline Products by Territory 22

3.3 COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) – Pipeline Products by Regulatory Path 24

3.4 COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) – Pipeline Products by Estimated Approval Date 25

3.5 COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) – Ongoing Clinical Trials 26

4 COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) – Pipeline Products under Development by Companies 27

4.1 COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Companies – Pipeline Products by Stage of Development 27

4.2 COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) – Pipeline Products by Stage of Development 31

5 COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Companies and Product Overview 36

5.1 20/20 GeneSystems Inc Company Overview 36

5.1.1 20/20 GeneSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.2 Abbott Diagnostics Company Overview 37

5.2.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 37

5.3 Abbott Laboratories Company Overview 42

5.3.1 Abbott Laboratories Pipeline Products & Ongoing Clinical Trials Overview 42

5.4 Absology Co Ltd Company Overview 43

5.4.1 Absology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

5.5 Abwiz Bio Inc Company Overview 44

5.5.1 Abwiz Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.6 Achira Labs Pvt Ltd Company Overview 45

5.6.1 Achira Labs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

5.7 ADiTx Therapeutics Inc Company Overview 46

5.7.1 ADiTx Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.8 ADMA Biologics Inc Company Overview 47

5.8.1 ADMA Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.9 AegirBio AB Company Overview 48

5.9.1 AegirBio AB Pipeline Products & Ongoing Clinical Trials Overview 48

5.10 Aegis Sciences Corp Company Overview 49

5.10.1 Aegis Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview 49

5.11 Affigenix Biosolutions Pvt Ltd Company Overview 50

5.11.1 Affigenix Biosolutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

5.12 Agilent Technologies Inc Company Overview 51

5.12.1 Agilent Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.13 ALPCO Diagnostics Company Overview 53

5.13.1 ALPCO Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 53

5.14 Anhui Deep Blue Medical Technology Co Ltd Company Overview 56

5.14.1 Anhui Deep Blue Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 56

5.15 Ansh Labs LLC Company Overview 59

5.15.1 Ansh Labs LLC Pipeline Products & Ongoing Clinical Trials Overview 59

5.16 Arrayit Corp Company Overview 60

5.16.1 Arrayit Corp Pipeline Products & Ongoing Clinical Trials Overview 60

5.17 ARUP Laboratories Company Overview 61

5.17.1 ARUP Laboratories Pipeline Products & Ongoing Clinical Trials Overview 61

5.18 Avacta Group Plc Company Overview 62

5.18.1 Avacta Group Plc Pipeline Products & Ongoing Clinical Trials Overview 62

5.19 Axim Biotechnologies Inc Company Overview 65

5.19.1 Axim Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.20 Axium BioResearch Inc Company Overview 67

5.20.1 Axium BioResearch Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.21 Babson Diagnostics Inc Company Overview 68

5.21.1 Babson Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.22 Base10 Genetics Inc Company Overview 70

5.22.1 Base10 Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.23 Beckman Coulter Inc Company Overview 71

5.23.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 71

5.24 Beijing Shengkun Kangru Medical Equipment Co Ltd Company Overview 73

5.24.1 Beijing Shengkun Kangru Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

5.25 Ben-Gurion University of the Negev Company Overview 74

5.25.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 74

5.26 Biohit Healthcare Ltd Company Overview 75

5.26.1 Biohit Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 75

5.27 BioIQ Inc Company Overview 77

5.27.1 BioIQ Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.28 Biolinker Synthetic Biology Ltd Company Overview 78

5.28.1 Biolinker Synthetic Biology Ltd Pipeline Products & Ongoing Clinical Trials Overview 78

5.29 Biomerica Inc Company Overview 79

5.29.1 Biomerica Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.30 Bio-Techne Corp Company Overview 80

5.30.1 Bio-Techne Corp Pipeline Products & Ongoing Clinical Trials Overview 80

5.31 BioVaxys Technology Corp Company Overview 81

5.31.1 BioVaxys Technology Corp Pipeline Products & Ongoing Clinical Trials Overview 81

5.32 Bloom Diagnostics AG Company Overview 84

5.32.1 Bloom Diagnostics AG Pipeline Products & Ongoing Clinical Trials Overview 84

5.33 Boston University Company Overview 85

5.33.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 85

5.34 BreviTest Technologies LLC Company Overview 86

5.34.1 BreviTest Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 86

5.35 Calviri Inc Company Overview 87

5.35.1 Calviri Inc Pipeline Products & Ongoing Clinical Trials Overview 87

5.36 Capricor Therapeutics Inc Company Overview 88

5.36.1 Capricor Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 88

5.37 CareHealth America Corp Company Overview 89

5.37.1 CareHealth America Corp Pipeline Products & Ongoing Clinical Trials Overview 89

5.38 Cellex Inc Company Overview 90

5.38.1 Cellex Inc Pipeline Products & Ongoing Clinical Trials Overview 90

5.39 Cellmid Ltd Company Overview 91

5.39.1 Cellmid Ltd Pipeline Products & Ongoing Clinical Trials Overview 91

5.40 Celltrion Inc Company Overview 92

5.40.1 Celltrion Inc Pipeline Products & Ongoing Clinical Trials Overview 92

5.41 Core Technology Co Ltd Company Overview 93

5.41.1 Core Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

5.42 DiaCarta Inc Company Overview 94

5.42.1 DiaCarta Inc Pipeline Products & Ongoing Clinical Trials Overview 94

5.43 Diagnostics Biochem Canada Inc Company Overview 95

5.43.1 Diagnostics Biochem Canada Inc Pipeline Products & Ongoing Clinical Trials Overview 95

5.44 DIALAB GmbH Company Overview 97

5.44.1 DIALAB GmbH Pipeline Products & Ongoing Clinical Trials Overview 97

5.45 DiaSorin SpA Company Overview 98

5.45.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 98

5.46 Diazyme Laboratories Inc Company Overview 99

5.46.1 Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 99

5.47 DLS Research and Ventures Company Overview 100

5.47.1 DLS Research and Ventures Pipeline Products & Ongoing Clinical Trials Overview 100

5.48 DRG International Inc Company Overview 101

5.48.1 DRG International Inc Pipeline Products & Ongoing Clinical Trials Overview 101

5.49 EDP Biotech Corporation Company Overview 103

5.49.1 EDP Biotech Corporation Pipeline Products & Ongoing Clinical Trials Overview 103

5.50 Empower Clinics Inc Company Overview 104

5.50.1 Empower Clinics Inc Pipeline Products & Ongoing Clinical Trials Overview 104

5.51 Enable Biosciences Inc Company Overview 105

5.51.1 Enable Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 105

5.52 Enzo Biochem Inc Company Overview 106

5.52.1 Enzo Biochem Inc Pipeline Products & Ongoing Clinical Trials Overview 106

5.53 Epigentek Group Inc Company Overview 107

5.53.1 Epigentek Group Inc Pipeline Products & Ongoing Clinical Trials Overview 107

5.54 Epitope Diagnostics, Inc. Company Overview 108

5.54.1 Epitope Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 108

5.55 Eurobio Scientific SA Company Overview 109

5.55.1 Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview 109

5.56 Eurofins Scientific SE Company Overview 110

5.56.1 Eurofins Scientific SE Pipeline Products & Ongoing Clinical Trials Overview 110

5.57 Euroimmun AG Company Overview 111

5.57.1 Euroimmun AG Pipeline Products & Ongoing Clinical Trials Overview 111

5.58 Excelsior Bio-Systems Inc Company Overview 115

5.58.1 Excelsior Bio-Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 115

5.59 Ezra AI Inc Company Overview 116

5.59.1 Ezra AI Inc Pipeline Products & Ongoing Clinical Trials Overview 116

5.60 Fujirebio Diagnostics Inc Company Overview 117

5.60.1 Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 117

5.61 General Biologicals Corp Company Overview 118

5.61.1 General Biologicals Corp Pipeline Products & Ongoing Clinical Trials Overview 118

5.62 Halberd Corp Company Overview 119

5.62.1 Halberd Corp Pipeline Products & Ongoing Clinical Trials Overview 119

5.63 Hecin Scientific Inc Company Overview 120

5.63.1 Hecin Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 120

5.64 Hunan Lituo Biotechnology Co Ltd Company Overview 121

5.64.1 Hunan Lituo Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 121

5.65 Icosagen AS Company Overview 122

5.65.1 Icosagen AS Pipeline Products & Ongoing Clinical Trials Overview 122

5.66 ICT International Company Overview 124

5.66.1 ICT International Pipeline Products & Ongoing Clinical Trials Overview 124

5.67 IDvet Company Overview 125

5.67.1 IDvet Pipeline Products & Ongoing Clinical Trials Overview 125

5.68 Immunodiagnostics Ltd Company Overview 126

5.68.1 Immunodiagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 126

5.69 ImmunoPrecise Antibodies Ltd Company Overview 128

5.69.1 ImmunoPrecise Antibodies Ltd Pipeline Products & Ongoing Clinical Trials Overview 128

5.70 Indian Institute of Technology Guwahati Company Overview 129

5.70.1 Indian Institute of Technology Guwahati Pipeline Products & Ongoing Clinical Trials Overview 129

5.71 Interpace Biosciences Inc Company Overview 130

5.71.1 Interpace Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 130

5.72 Kantaro Biosciences LLC Company Overview 131

5.72.1 Kantaro Biosciences LLC Pipeline Products & Ongoing Clinical Trials Overview 131

5.73 Kephera Diagnostics LLC Company Overview 132

5.73.1 Kephera Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 132

5.74 KRISHGEN BioSystems Company Overview 133

5.74.1 KRISHGEN BioSystems Pipeline Products & Ongoing Clinical Trials Overview 133

5.75 Lansion Biotechnology Co Ltd Company Overview 140

5.75.1 Lansion Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 140

5.76 Leadgene Biomedical Inc Company Overview 141

5.76.1 Leadgene Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 141

5.77 Leinco Technologies Inc Company Overview 142

5.77.1 Leinco Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 142

5.78 Liquid Diagnostics LLC Company Overview 143

5.78.1 Liquid Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 143

5.79 Lumos Diagnostics Inc Company Overview 144

5.79.1 Lumos Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 144

5.80 Maxim Biomedical Inc Company Overview 145

5.80.1 Maxim Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 145

5.81 Meridian Bioscience Inc Company Overview 148

5.81.1 Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 148

5.82 Module Innovations Pvt Ltd Company Overview 149

5.82.1 Module Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 149

5.83 Mologic Ltd Company Overview 150

5.83.1 Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview 150

5.84 Monarch Global Health LLC Company Overview 153

5.84.1 Monarch Global Health LLC Pipeline Products & Ongoing Clinical Trials Overview 153

5.85 Monopar Therapeutics Inc Company Overview 154

5.85.1 Monopar Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 154

5.86 Nanjing Liming Bio-Products Co Ltd Company Overview 155

5.86.1 Nanjing Liming Bio-Products Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 155

5.87 NanoRepro AG Company Overview 156

5.87.1 NanoRepro AG Pipeline Products & Ongoing Clinical Trials Overview 156

5.88 Nirmidas Biotech Inc Company Overview 157

5.88.1 Nirmidas Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 157

5.89 Northwestern University Company Overview 158

5.89.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 158

5.90 Novacyt SA Company Overview 159

5.90.1 Novacyt SA Pipeline Products & Ongoing Clinical Trials Overview 159

5.91 NovaTec Immundiagnostica GmbH Company Overview 160

5.91.1 NovaTec Immundiagnostica GmbH Pipeline Products & Ongoing Clinical Trials Overview 160

5.92 Novo Nordisk AS Company Overview 163

5.92.1 Novo Nordisk AS Pipeline Products & Ongoing Clinical Trials Overview 163

5.93 OraSure Technologies Inc Company Overview 165

5.93.1 OraSure Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 165

5.94 Ortho Clinical Diagnostics Holdings Plc Company Overview 166

5.94.1 Ortho Clinical Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 166

5.95 Oy Medix Biochemica Ab Company Overview 169

5.95.1 Oy Medix Biochemica Ab Pipeline Products & Ongoing Clinical Trials Overview 169

5.96 P3 Diagnostics LLC Company Overview 170

5.96.1 P3 Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 170

5.97 Pepex Biomedical, Inc. Company Overview 171

5.97.1 Pepex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 171

5.98 PerkinElmer Inc Company Overview 172

5.98.1 PerkinElmer Inc Pipeline Products & Ongoing Clinical Trials Overview 172

5.99 Pinnacle BioLabs Company Overview 173

5.99.1 Pinnacle BioLabs Pipeline Products & Ongoing Clinical Trials Overview 173

5.100 Prantae Solutions Pvt Ltd Company Overview 174

5.100.1 Prantae Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 174

5.101 Premier Medical Corporation Company Overview 175

5.101.1 Premier Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 175

5.102 ProAxsis Ltd Company Overview 176

5.102.1 ProAxsis Ltd Pipeline Products & Ongoing Clinical Trials Overview 176

5.103 ProGnosis Biotech SA Company Overview 177

5.103.1 ProGnosis Biotech SA Pipeline Products & Ongoing Clinical Trials Overview 177

5.104 Promega Corp Company Overview 179

5.104.1 Promega Corp Pipeline Products & Ongoing Clinical Trials Overview 179

5.105 ProMIS Neurosciences Inc Company Overview 180

5.105.1 ProMIS Neurosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 180

5.106 Qiagen NV Company Overview 181

5.106.1 Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview 181

5.107 Qlife Holding AB Company Overview 185

5.107.1 Qlife Holding AB Pipeline Products & Ongoing Clinical Trials Overview 185

5.108 Quanterix Corp Company Overview 186

5.108.1 Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 186

5.109 Quotient Ltd Company Overview 188

5.109.1 Quotient Ltd Pipeline Products & Ongoing Clinical Trials Overview 188

5.110 Randox Laboratories Ltd Company Overview 189

5.110.1 Randox Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview 189

5.111 Roche Diagnostics International Ltd Company Overview 190

5.111.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 190

5.112 Safetest Comercio de Diagnosticos Ltd Company Overview 194

5.112.1 Safetest Comercio de Diagnosticos Ltd Pipeline Products & Ongoing Clinical Trials Overview 194

5.113 Salofa Oy Company Overview 195

5.113.1 Salofa Oy Pipeline Products & Ongoing Clinical Trials Overview 195

5.114 ScheBo Biotech AG Company Overview 196

5.114.1 ScheBo Biotech AG Pipeline Products & Ongoing Clinical Trials Overview 196

5.115 Sciteck Diagnostics Inc Company Overview 197

5.115.1 Sciteck Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 197

5.116 Shenzhen Kingfocus Biomedical Engineering Co Ltd Company Overview 198

5.116.1 Shenzhen Kingfocus Biomedical Engineering Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 198

5.117 Shenzhen Tisenc Medical Devices Co Ltd Company Overview 199

5.117.1 Shenzhen Tisenc Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 199

5.118 Shijiazhuang Hipro Biotechnology Co Ltd Company Overview 200

5.118.1 Shijiazhuang Hipro Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 200

5.119 Siemens Healthcare Diagnostics Inc Company Overview 201

5.119.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 201

5.120 Siemens Healthineers AG Company Overview 204

5.120.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 204

5.121 SQI Diagnostics Inc Company Overview 206

5.121.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 206

5.122 St Petersburg Research Institute of Vaccines and Serums Company Overview 209

5.122.1 St Petersburg Research Institute of Vaccines and Serums Pipeline Products & Ongoing Clinical Trials Overview 209

5.123 Stream Bio Ltd Company Overview 210

5.123.1 Stream Bio Ltd Pipeline Products & Ongoing Clinical Trials Overview 210

5.124 Syngene Company Overview 211

5.124.1 Syngene Pipeline Products & Ongoing Clinical Trials Overview 211

5.125 Sysmex Corp Company Overview 212

5.125.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 212

5.126 Taizhou ZECEN Biotech Co Ltd Company Overview 214

5.126.1 Taizhou ZECEN Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 214

5.127 The Binding Site Inc Company Overview 219

5.127.1 The Binding Site Inc Pipeline Products & Ongoing Clinical Trials Overview 219

5.128 ThermoGenesis Holdings Inc Company Overview 220

5.128.1 ThermoGenesis Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 220

5.129 Trinity College Dublin Company Overview 221

5.129.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 221

5.130 University of Melbourne Company Overview 222

5.130.1 University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 222

5.131 VidaCheck LLC Company Overview 223

5.131.1 VidaCheck LLC Pipeline Products & Ongoing Clinical Trials Overview 223

5.132 VirIntel LLC Company Overview 224

5.132.1 VirIntel LLC Pipeline Products & Ongoing Clinical Trials Overview 224

5.133 Vivera Pharmaceuticals Inc Company Overview 225

5.133.1 Vivera Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 225

5.134 Vyriad Inc Company Overview 226

5.134.1 Vyriad Inc Pipeline Products & Ongoing Clinical Trials Overview 226

5.135 West Virginia University School of Medicine Company Overview 227

5.135.1 West Virginia University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 227

5.136 Zalgen Labs LLC Company Overview 228

5.136.1 Zalgen Labs LLC Pipeline Products & Ongoing Clinical Trials Overview 228

5.137 Zandcell AB Company Overview 233

5.137.1 Zandcell AB Pipeline Products & Ongoing Clinical Trials Overview 233

5.138 ZRT Laboratory LLC Company Overview 234

5.138.1 ZRT Laboratory LLC Pipeline Products & Ongoing Clinical Trials Overview 234

6 Appendix 236

6.1 Methodology 236

6.2 About GlobalData 239

6.3 Contact Us 239

Frequently asked questions

COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

  • Access a live COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.